Home - Open Targets (original) (raw)
Three reflections from David Hulcoop's first year as Executive Director
David Hulcoop
13 August 2024
Tutorial: Introducing the Open Targets Standalone Deployment Tool
Manuel Bernal Llinares
2 July 2024
Open Targets Platform 24.06 has been released!
Sir Target
19 June 2024
How Ana Cvejic built an immune atlas of lung cancer
Helena Cornu
23 May 2024
Integrating pharmacogenetics data: a new lens for target prioritisation
Irene López Santiago, April Shen
9 May 2024
Open Targets Platform 24.03 has been released!
Sir Target
20 March 2024
Q&A with Lucy Sibbring, an intern with the Open Targets data team
Helena Cornu
29 February 2024
Open Targets Platform 23.12 has been released!
Sir Target
30 November 2023
Q&A with Jason Menkiti, an intern with the Open Targets data team
Helena Cornu
8 November 2023
Case study: NCI’s Molecular Targets Platform
Annalisa Buniello
31 October 2023
Case study: Extracting tidy data from Open Targets Genetics with Otargen
Helena Cornu
24 October 2023
Open Targets Platform 23.09 has been released!
Sir Target
21 September 2023
Welcome to new Director David Hulcoop
Helena Cornu
21 September 2023
Helena Cornu
15 August 2023
Meet Yakov Tsepilov, our new Genetics team leader
Helena Cornu
7 August 2023
Open Targets Platform 23.06 has been released!
Sir Target
26 June 2023
Case study: Open Targets at your fingertips with Raycast
Helena Cornu, Irene López Santiago
20 June 2023
Case study: Querying the Open Targets Platform using natural language
Helena Cornu
25 May 2023
Code breaking and the Human Genome Project
Ian Dunham
25 April 2023
A leading scientist in the sequencing of the human genome, Ian Dunham reflects on the early years of the Wellcome Sanger Institute.
How Emmanouil Metzakopian is finding gene targets to treat neurodegeneration
Helena Cornu
5 April 2023
Manos Metzakopian discusses his latest research, in which the team validated KAT2B gene knockouts as neuroprotective against ER stress.